NCT02041624终止不适用
An International Non-Interventional Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis Treated With Oralair®.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 740
- 试验地点
- 1
- 主要终点
- Health related quality of life
研究概览
简要总结
The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR® over a follow-up period up to 5 years, in real-life settings.
详细描述
Primary objective:
To describe the patient's perception of the impact of ORALAIR® on his/her health related generic and disease specific quality of life during the grass pollen season in real-life settings.
Secondary objectives:
- To describe the patient's perceived effectiveness of ORALAIR® in allergic rhinoconjunctivitis management in terms of disease intensity, satisfaction and rescue medication
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 5 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient of 5 years of age and older at the date of the screening visit
- •Patient with proven allergic rhino-conjunctivitis due to grass pollen
- •Patient eligible for a grass-pollen Allergen ImmunoTherapy (AIT)
- •Patient whose physician prescribed ORALAIR® independently of the study, before the beginning of the grass-pollen season
排除标准
- •Patient participating in a clinical trial or in an epidemiological study
结局指标
主要结局
Health related quality of life
时间窗: patients will be followed for the duration of the treatment, an expected average of 6 months/year
The primary objective is to describe the patient's perception of the impact of ORALAIR® on his/her health related generic and disease specific quality of life during the grass-pollen season in real-life settings.
次要结局
- Treatment Effectiveness(patients will be followed for the duration of the treatment, an expected average of 6 months/year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Health-related Quality of Life in Patients on AnticoagulantsAtrial FibrillationNCT03134911Boehringer Ingelheim535
已完成
不适用
Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) IndicationVenous ThrombosisNCT01805544Bayer113
已完成
不适用
Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) IndicationAtrial FibrillationNCT01805531Bayer411
已完成
不适用
A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in AdultsPlaque PsoriasisNCT05811234Almirall, S.A.291
招募中
不适用
Investigation on the quality of life and patient-centered outcome measures of parents and children with polycystic kidney diseasesQ61.1Q61.2Polycystic kidney, autosomal recessivePolycystic kidney, autosomal dominantDRKS00021059niversitätsklinikum Freiburg50